Age-related sporadic disease
Typical setting: Risk rises strongly with age through interacting protein-clearance, vascular, immune, and resilience changes.
Multifactorial biology permits amyloid and tau pathology to accumulate over years before symptoms.
APOE-associated susceptibility
Typical setting: APOE variants alter lipid transport, amyloid handling, and inflammatory response.
An e4 allele raises population risk but does not diagnose an individual or predict an inevitable outcome.
Autosomal dominant Alzheimer's disease
Typical setting: Rare APP, PSEN1, or PSEN2 variants cause younger-onset familial disease.
Altered amyloid processing produces highly penetrant pathology and requires specialist genetic counselling.
Down syndrome
Typical setting: An additional chromosome 21 increases APP gene dosage.
Amyloid pathology develops earlier, though cognitive diagnosis requires comparison with the person's own baseline.
Vascular and lifestyle contributors
Typical setting: Hypertension, diabetes, smoking, inactivity, hearing loss, and social isolation influence lifetime dementia risk.
They may reduce reserve, add vascular injury, or interact with neurodegenerative pathology.